Exelixis Inc reports results for the quarter ended in September - Earnings Summary

Exelixis

02/11/2023 02:02

* Exelixis Inc  EXEL.OQ  reported quarterly breakeven
results​​
per share for the quarter ended in September, lower than the
same quarter last year, when the company reported EPS of 23
cents.  The mean expectation of seventeen analysts for the
quarter was for earnings of 10 cents per share. Wall Street
expected results to range from -13 cents to 26 cents per share.
    * Revenue rose 14.6% to $471.92 million from a year ago;
analysts
expected $473.58 million. 
    * Exelixis Inc's reported EPS for the quarter was breakeven
results​.
    * The company reported quarterly net income of $1.04
million.
    * Exelixis Inc shares had fallen by 5.8% this quarter and
gained 28.4% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 47.6%
in the last three months.​ 
    * In the last 30 days, eight analysts negatively revised
earnings
estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 14 "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Exelixis Inc is
$27.00 
This summary was machine generated from LSEG data November 2 at
02:02 a.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2023      0.10           0.00           Missed
 Jun. 30 2023      0.16           0.25           Beat
 Mar. 31 2023      0.15           0.12           Missed
 Dec. 31 2022      -0.12          -0.09          Beat